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Abstract 
Mutations in calpain-3 cause limb girdle muscular dystrophy 2A. Biopsy pathology is 
typically dystrophic, sometimes characterized by frequent lobulated fibres. More recently 
calpain mutations have been shown in association with eosinophilic myositis, suggesting 
that calpain mutations may render muscle susceptible to inflammatory change.  We present 
the case of a 33-year old female with mild proximal muscle weakness and high CK levels 
(6698 IU/L at presentation). Muscle biopsy showed clusters of fibre necrosis associated with 
very dense macrophage infiltrates and small numbers of lymphocytes, raising the possibility 
of an inflammatory myopathy. No eosinophils were observed. Immunosuppressive 
treatment was started without clinical improvement. MRI demonstrated bilateral fatty 
replacement in posterior thigh and calf muscles. Western blot results prompted Sanger 
sequencing of the calpain-3 gene revealing compound heterozygous mutations 
c.643_663del and c.1746-20C>G. Our case widens the myopathological spectrum of 
calpainopathies to include focal macrophage rich inflammatory change.  
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Introduction 
Mutations in the calpain-3 gene (CAPN3) cause Limb girdle muscular dystrophy 2A. Muscle 
biopsy often shows dystrophic changes, sometimes with prominent lobulated fibres. More 
recently calpain-3 mutations have been found in paediatric and adult patients with 
eosinophilic myositis, indicating that calpainopathy can also result in inflammatory changes 
in muscle. We diagnosed calpainopathy in a patient with regional macrophage rich myositis, 
suggesting an extension of the inflammatory phenotype.  
 
Case report 
A 33 year old female patient was referred to us with a one and a half year history of mildly 
progressive lower limb proximal weakness. She did not have previous neuromuscular 
complaints and had normal motor milestones in childhood, although mild scoliosis had been 
present since an early age. On examination she had mildly abnormal gait, and was unable to 
stand from squatting. Muscle strength in her lower limbs was reduced for hip flexion and 
adduction at 4/5 MRC bilaterally. Upper limb strength was normal but there was scapular 
winging. There was no facial weakness or dysphagia. Sensory examination was normal. Her 
CK level was 6698 IU/L. Family history was negative for neuromuscular conditions  with the 
possible exception of her sister who had moderate scoliosis since age 12 and joint 
hypermobility. 
Examination of a muscle biopsy from left quadriceps revealed increased variability in fibre 
size with scattered round smaller fibres, occasional internal nuclei, and mildly increased 
endomysial connective tissue in all fascicles (Fig. 1). In addition, several distinct regions 
within different fascicles demonstrated sheets of necrotic or small basophilic fibres with 
large internal nuclei, accompanied by a dense cellular infiltrate composed predominantly of 
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macrophages with some lymphocytes. Eosinophils were not observed. 
Necrotic/regenerating regions appeared to respect fascicular boundaries with some 
fascicles quite unaffected. Immunohistochemistry confirmed a dense macrophage infiltrate 
(CD68) in these areas with moderate numbers of T-cells (CD3) of which a small proportion 
were CD8-positive. The disproportionate presence of macrophages accompanied by a 
moderate lymphocyte infiltrate supports a description as macrophage rich inflammatory 
process. Small basophilic fibres were generally positive for neonatal myosin with increased 
sarcolemmal expression of utrophin and MHC Class I. Normal appearing fibres in the 
remainder of the biopsy did not show this profile, nor was there a significant inflammatory 
infiltrate. Complement membrane attack complex (MAC) deposits were prominent in 
necrotic fibres and occasional scattered normal appearing fibres showed granular 
sarcolemmal deposits. There was no capillary MAC labelling.  Several vessels had plump 
endothelial cells, but there was no evidence of vasculitis. An immunohistochemical 
dystrophy panel was normal, including dysferlin staining. Electron microscopy was not 
performed. 
The areas of necrosis and marked inflammatory infiltration raised concern for an immune 
mediated process, possibly in the spectrum of immune myopathy with abundant 
macrophages, dermatomyositis with regional infarction, or vasculitis with microinfarction. 
After initial observation, immunosuppressive therapy with azathioprine was started. 
Although subjective improvement was reported, there was minimal clinical improvement 
and CK levels were only mildly reduced to around 2500 IU/L.  
Muscle MRIwhile on immunosuppressive therapy revealed fatty replacement of adductor 
magnus and posterior thigh muscles, soleus, and medial gastrocnemius bilaterally (Fig. 2). 
There was no increased water content on STIR sequence. MRI examination of the patient's 
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sister showed similar results. Suspicion of a dystrophic process increased and azathioprine 
treatment was discontinued without subsequent clinical change. . 
Following these investigations, Western blot analysis was initiated. There were no bands 
detected on probing with calpain-3 exon 1 antibody (Fig. 3). Exon 8 antibody revealed a 
barely detectable band for the full sized protein but no degradation bands. Sanger 
sequencing demonstrated a compound heterozygous state for a pathogenic in-frame 
deletion (c.643_663del [p.Ser215_Gly221del]) and a splice site mutation (c.1746-20C>G; [1]) 
in CAPN3. 
 
Discussion 
The present case illustrates regional macrophage rich inflammation with fascicular 
distribution in a patient with late onset, mild proximal lower limb weakness, scapular 
winging, and mild scoliosis. Calpainopathy was diagnosed based on Western blot and Sanger 
sequencing. Symmetric fatty replacement of muscles in the posterior thigh compartment 
and superficial posterio-medial calf compartment were in keeping with a calpain-3 
mutation.  
Histological findings prompted the initial suspicion of an inflammatory myopathy with 
subsequent azathioprine treatment. Macrophage-rich inflammation is not generally known 
to be associated with a hereditary condition, as opposed to, for instance, lymphocyte rich 
inflammation in dysferlinopathy or eosinophilic myositis in calpainopathy. The pattern of 
muscle involvement on MRI together with a similar pattern in the patient’s sister provided a 
clue to pursue the possibility of a hereditary condition more vigorously, illustrating the 
potential importance of this diagnostic modality.  
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Although clearly inflammatory in nature, the muscle biopsy result was not indicative of a 
specific inflammatory myopathy. Regionality and selective fascicular involvement with 
numerous macrophages were striking histological features. These findings may raise a 
histological differential including immune myopathy with abundant macrophages (IMAM), 
dermatomyositis with microinfarcts, or vasculitis with microinfarcts. However, MHC class I 
expression was restricted to regenerating fibres arguing against a diffuse inflammatory 
process. There was no capillary membrane attack complex (MAC) deposition, which might 
be expected in dermatomyositis with regional infarcts. There was also no evidence of 
vasculitis. Although these findings did not support an immune mediated process, they were 
equally insufficient to exclude it. 
Regional necrosis is not typically reported as a biopsy feature of calpainopathy, but has 
previously been noted in a single report of two patients homozygous for R110X in CAPN3. 
However, prominent inflammatory infiltrates were absent [2]. Larger series of eosinophilic 
myositis with calpainopathy mostly report focal inflammation in association with regional 
necrosis, with some micrographs demonstrating similar fascicular involvement as in our case 
[3, 4]. Nevertheless, the presence of eosinophils is thought to be a pointer in these 
instances. The present case indicates that the inflammatory infiltrate may also be 
predominantly composed of macrophages without eosinophils. Taken together, present 
evidence indicates that regional or fascicular necrosis and regeneration can occur in 
calpainopathy and may be associated with eosinophilic, macrophage rich, or scanty 
inflammatory infiltrates.  
This case also illustrates our increasing understanding of the variability of biopsy findings in 
both inflammatory and hereditary conditions, and broadens the spectrum of inflammatory 
manifestations of limb girdle muscular dystrophies. It also illustrates the utility of MRI 
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investigations for the diagnosis of muscle conditions in adults. In the future, the routine use 
of panel sequencing approaches may further increase diagnostic efficiency. The present 
case would recommend a liberal use of panel approaches when biopsy reveals equivocal 
inflammatory findings. 
 
Conclusion 
The histological phenotype of calpain-3 mutations extends to macrophage-rich inflammatory 
infiltrates in a regional distribution and should be considered in its differential alongside 
microinfarcts and IMAM. 
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